Pro Medicus Ltd (ASX: PME) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Pro Medicus Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $6.08 billion
P/E Ratio 250.00
Dividend Yield 0.22%
Shares Outstanding 104.21 million
Earnings per share 0.235
Dividend per share 0.14
Year To Date Return 70.99%
Earnings Yield 0.40%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of May 24th 2021

Pro Medicus Ltd (ASX: PME)
Latest News

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
04 Mar 2021 $0.0700 100.00% Interim 19 Mar 2021
10 Sep 2020 $0.0600 100.00% Final 02 Oct 2020
05 Mar 2020 $0.0600 100.00% Interim 20 Mar 2020
12 Sep 2019 $0.0450 100.00% Final 04 Oct 2019
12 Mar 2019 $0.0250 100.00% Special Cash 17 May 2019
07 Mar 2019 $0.0350 100.00% Interim 22 Mar 2019
06 Sep 2018 $0.0350 100.00% Final 27 Sep 2018
08 Mar 2018 $0.0250 100.00% Interim 23 Mar 2018
07 Sep 2017 $0.0250 100.00% Final 28 Sep 2017
08 Sep 2016 $0.0150 0.00% Final 29 Sep 2016
10 Mar 2016 $0.0150 0.00% Interim 24 Mar 2016
09 Sep 2015 $0.0100 0.00% 02 Oct 2015
04 Mar 2015 $0.0100 0.00% 20 Mar 2015
10 Sep 2014 $0.0100 100.00% 03 Oct 2014

PME ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Pro Medicus Ltd

Pro Medicus Limited (ASX: PME) provides healthcare imaging software and services to hospitals, diagnostic imaging groups and other health related entities in Australia, North America and Europe.

The company is a leading provider of radiology information systems (RIS), picture archiving and communication systems (PACS) and advanced visualisation solutions across the globe. It has more than 30 years’ experience in helping clients deliver first-rate patient care by enhancing and streamlining medical practice management.

Primary products for RIS include medical accounting, clinical reporting, appointments/scheduling and marketing/ management information applications.

After explosive growth in 2019, the Pro Medicus share price has been able to successfully navigate the impacts of COVID-19 in 2020.

PME Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
23 Jul 2021 $58.34 $0.50 0.86% 97,527 $57.79 $58.34 $57.42
22 Jul 2021 $57.84 $-0.33 -0.57% 132,783 $58.50 $58.82 $57.18
21 Jul 2021 $58.17 $-1.30 -2.19% 121,756 $59.58 $59.91 $58.02
20 Jul 2021 $59.47 $0.57 0.97% 214,959 $58.90 $60.55 $58.82
19 Jul 2021 $58.90 $-0.10 -0.17% 111,370 $59.06 $59.74 $58.80
16 Jul 2021 $59.00 $0.75 1.29% 137,449 $57.74 $59.04 $57.65
15 Jul 2021 $58.25 $0.27 0.47% 204,333 $57.52 $58.67 $57.15
14 Jul 2021 $57.98 $-1.22 -2.06% 165,336 $59.09 $59.70 $57.59
13 Jul 2021 $59.20 $1.72 2.99% 183,373 $58.10 $59.90 $57.83
12 Jul 2021 $57.48 $1.25 2.22% 116,472 $56.10 $57.79 $55.87
09 Jul 2021 $56.23 $-1.05 -1.83% 174,349 $57.27 $57.27 $55.85
08 Jul 2021 $57.28 $-0.18 -0.31% 156,385 $57.61 $58.17 $56.93
07 Jul 2021 $57.46 $2.24 4.06% 128,540 $56.00 $57.81 $55.69
06 Jul 2021 $55.22 $-0.98 -1.74% 125,248 $56.01 $56.70 $55.00
05 Jul 2021 $56.20 $-0.47 -0.83% 153,360 $56.67 $57.20 $55.88
02 Jul 2021 $56.67 $-0.21 -0.37% 117,117 $57.03 $57.38 $56.09
01 Jul 2021 $56.88 $-1.84 -3.13% 212,819 $58.10 $58.23 $56.68
30 Jun 2021 $58.72 $0.81 1.40% 197,742 $58.50 $59.22 $57.80
29 Jun 2021 $57.91 $0.91 1.60% 177,491 $56.99 $58.12 $56.40
28 Jun 2021 $57.00 $0.12 0.21% 155,833 $57.04 $57.05 $56.33
25 Jun 2021 $56.88 $0.01 0.02% 208,021 $57.10 $57.54 $56.40

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
18 Feb 2021 Sam Hupert Sell 1 $45,970,000
On-market trade.
18 Feb 2021 Anthony Hall Sell 1 $45,970,000
On-market trade.
21 Aug 2020 Deena Shiff Buy 1 $49,998
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Dr Sam Aaron Hupert Chief Executive OfficerManaging Director Oct 2007
Dr Hupert commenced General Practice in 1980. Realising the potential for computers in medicine he left general practice in late 1984 to devote himself to managing the Group.
Mr Anthony Barry Hall Executive DirectorTechnology Director Jan 1983
Mr Hall has been principal architect and developer of the core software systems. His current focus is the transition to and development of the Company's next generation RIS systems.
Mr Peter Terence Kempen Non-Executive ChairmanNon-Executive Director Mar 2008
Mr Kempen is Chairman of Australasian Leukaemia and Lymphoma Group and Chairman of LogieSmith Lanyon. He is also a Trustee of the Barr Family Foundation and a Member of the Board of St Hilda's College Ltd, University of Melbourne. He has previously been Chairman of Patties Food Limited, Danks Holdings Limited, Ivanhoe Grammar School and Managing Partner of Ernst & Young Corporate Finance Australia.
Ms Deena Robyn Shiff Non-Executive Director Aug 2020
Ms Shiff has had a senior legal career followed by a senior executive career in Australian telecommunications. Her subsequent board career as a Chairman/Non-Executive Director, has included a number of boards of global infrastructure and ICT companies. Deena was the first woman Group Managing Director at Telstra running Telstra Wholesale and establishing and running Telstra Business, a division focused on the SME market. In 2011 Deena established Telstra's corporate venture capital arm, Telstra Ventures before leaving in 2013 to focus on a full time Board career. Deena is currently Chair of Marley Spoon AG and a Non-Executive Director of Appen Ltd, both of which are listed on the ASX. She also holds a number of positions on Government and Not for Profit Boards.
Mr Anthony James Glenning Non-Executive Director May 2016
Mr Glenning is the fund manager of Skalata Ventures. He is Chairman of Cyrise Pty Ltd. He has previously been Investment Director of Starfish Ventures and was the founder and previously the CEO of Tonic Systems and a founder & Non-Executive Director of Cameron Systems.
Dr Leigh Bernard Farrell Non-Executive Director Sep 2017
Mr Farrell is Executive Director of AdNED Pty Ltd and was previously Vice President, Commercial of Certara USA, Inc. Prior to this, he was Chairman and COO of d3 Medicine LLC.
Mr Clayton James Hatch Chief Financial OfficerCompany Secretary Jul 2009
-
Clayton James Hatch Chief Financial OfficerCompany Secretary
-
Danny Tauber General Manager - Pro Medicus Limited
-
Brad Levin General Manager - Visage Imaging Inc
-
Sean Lambright Global Head of Sales - Visage Imaging Inc.
-
Malte Westerhoff Managing Director - Visage Imaging GmbH
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Dr S Hupert 28,137,660 27.07%
Mr A Hall 28,109,000 27.04%
Hsbc Custody Nominees (Australia) Limited 11,618,835 11.18%
J P Morgan Nominees Australia Limited 5,458,034 5.25%
Citicorp Nominees Pty Ltd 3,268,267 3.14%
National Nominees Limited 1,423,797 1.37%
HSBC Custody Nominees (Australia) Limited Gsco Eca 1,258,057 1.21%
BNP Paribas Noms Pty Ltd 1,009,441 0.97%
BNP Parabis Nominees Pty Ltd 857,364 0.82%
Mr Bram Vander Jagt & Mrs Maaike Vander Jagt 700,000 0.67%
Mr Peter Terence Kempen & Mrs Elaine Margaret Kempen 678,082 0.65%
Grain Exporters (Australia) Pty Ltd 585,668 0.56%
Mr Danny Tauber 380,915 0.37%
Mr Kenneth John Vander Jagt & Mrs Tanya Vander Jagt 364,020 0.35%
Mr Roderick Lyle 340,000 0.33%
Mr Stephen Geoffrey Wilson & Ms Denise Adele Prandi 300,037 0.29%
Mr Evan Philip Clucas and Ms Leanne Jane Weston 287,980 0.28%
Mr Colin Gregory Organ 271,000 0.26%
Mr John Charles Plummer 250,000 0.24%
Mr Michael Wu 239,942 0.23%

Frequently Asked Questions

Pro Medicus is a leading imaging IT provider that provides radiology IT software and services to hospitals, imaging centers and health care groups worldwide. 

PME’s most recent dividend payment was made to shareholders March 20, with the distribution amount being $0.06.

Profile

since

Note